Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 350 | -5,790 | -4,710 | -25,390 | -3,240 |
| Depreciation Amortization | 100 | 120 | 400 | 130 | 70 |
| Other Working Capital | -1,120 | 1,450 | N/A | N/A | N/A |
| Other Operating Activity | 10 | 1,230 | 620 | 20,540 | -400 |
| Operating Cash Flow | $-660 | $-2,990 | $-3,690 | $-4,720 | $-3,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -40 | N/A | N/A | N/A |
| Other Investing Activity | -10 | -250 | -570 | -1,340 | -230 |
| Investing Cash Flow | $-20 | $-290 | $-570 | $-1,340 | $-230 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,440 | 2,970 | 3,250 | 4,540 | 5,380 |
| Financing Cash Flow | $1,440 | $2,970 | $3,250 | $4,540 | $5,380 |
| Beginning Cash Position | 260 | 570 | 1,580 | 3,110 | 1,530 |
| End Cash Position | 1,020 | 260 | 570 | 1,580 | 3,110 |
| Net Cash Flow | $750 | $-310 | $-1,000 | $-1,520 | $1,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -660 | -2,990 | -3,690 | -4,720 | -3,570 |
| Free Cash Flow | -660 | -2,990 | -3,690 | -4,720 | -3,570 |